FDA Should Release Existing Supply Of Primatene Mist OTC Asthma Inhaler, Rep. Says
This article was originally published in The Tan Sheet
Executive Summary
Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.